GLINTA (Linagliptin INN 5 mg) x 30 TABLETS.
Generic name: Linagliptin
Brand name: Renata.
Class: DPP-4 Inhibitor (Dipeptidyl Peptidase-4 Inhibitor).
Pack size: 30 Tablets.
Form: Tablets.
Strength: 5 mg.
Amount: ₦‎9,400

Description: Glinta contains Linagliptin, a DPP-4 inhibitor used to improve blood sugar control in adults with type 2 diabetes. It works by increasing the levels of incretin hormones, which help regulate insulin and decrease glucose production in the liver.

Key features:
• Effective Glycemic Control: Helps manage blood sugar levels in type 2 diabetes.
• DPP-4 Inhibitor: Increases incretin hormone levels to regulate insulin and reduce glucose production.
• Convenient Dosage: Once-daily tablet for ease of use.
• Monotherapy or Combination Therapy: Can be used alone or with other antidiabetic medications.

Side effects:
• Common side effects may include nasopharyngitis, hypoglycemia (especially when used with sulfonylureas or insulin), and cough.

Caution:
• Prescription Only: Use under the guidance of a healthcare professional.
• Monitor Blood Sugar Levels: Regular monitoring of blood sugar levels to ensure effectiveness.
• Pregnancy and Breastfeeding: Consult your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
• Caution in Kidney Impairment: Not recommended for patients with severe renal impairment or end-stage renal disease.
• Keep out of sight and reach of children.